Truist Financial Boosts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $200.00
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by investment analysts at Truist Financial from $190.00 to $200.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price target points to a potential upside of 54.86% from the […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price increased by investment analysts at Truist Financial from $190.00 to $200.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price target points to a potential upside of 54.86% from the […]
